I-SPY essais cliniques.pptx
Sophie Skorupka, Stéphanie Crosetto, Hasnein Cheikh,
Juliette Desbonnet
AREIPS 2016-2017
Breast
Cancer
Key numbers
France, 2014 USA, 2014
Cancer Incidence
3
Breast Cancer I-SPY 1 I-SPY 2 I-SPY 3 Limits of I-SPYAccelerated Approval
Key numbers
http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp 4
0
20
40
60
80
100
120
1980 1985 1990 1995 2000 2005 2010
Age-standardised rate per 100 000
Evolution of incidence
France USA
0
5
10
15
20
25
1975 1980 1985 1990 1995 2000 2005 2010
Age-standardised rate per 100 000
Evolution of mortality
France USA
Breast Cancer I-SPY 1 I-SPY 2 I-SPY 3 Limits of I-SPYAccelerated Approval
5
Breast anatomy
Breast Cancer I-SPY 1 I-SPY 2 I-SPY 3 Limits of I-SPYAccelerated Approval
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
1
/
88
100%
